Elevated Ratio of Urinary Metabolites of Thromboxane and Prostacyclin Is Associated with Adverse Cardiovascular Events in ADAPT
Thomas J. Montine, Joshua A. Sonnen, Ginger Milne et al. · 2010
Read Elevated Ratio of Urinary Metabolites of Thromboxane and Prostacyclin Is Associated with Adverse Cardiovascular Events in ADAPT by Thomas J. Montine, Joshua A. Sonnen, Ginger Milne et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009340.txt.
Description
Thomas Montine and co-authors published this heart risk study in PLOS ONE in 2010. Pain drugs called NSAIDs had come under suspicion for causing heart attacks and strokes. The data came partly from ADAPT, a trial testing anti-inflammatory drugs to prevent Alzheimer's disease. The authors looked for a warning signal in urine chemistry.
They measured breakdown products of thromboxane and prostacyclin, two signals that balance blood clotting. A high ratio between them was linked to later bad cardiovascular events. Such a urine marker could flag risky patients before harm occurs. It also hints at how these pain drugs upset the clotting balance.
Catalog record
| CREATOR | Thomas J. Montine, Joshua A. Sonnen, Ginger Milne et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009340